✦ LIBER ✦

EPA-1551 - Paliperidone palmitate – impact on negative, disorganized and depressive symptoms, subjective well-being and patient satisfaction in patients with schizophrenia previously unsuccessfully treated with oral antipsychotics

✍ Scribed by Schreiner, A.; Hargarter, L.; Bergmans, P.; Cherubin, P.; Rancans, E.; Bez, Y.; Parellada, E.; Carpiniello, B.; Vidailhet, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster #M243 PALIPERIDONE PALMITATE – IM

✍ Schreiner, Andreas; Hargarter, Ludger; Bergmans, Paul; Cherubin, Pierre; Rancans 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

EPA-1545 - Functional outcomes with once

✍ Hargarter, L.; Bergmans, P.; Cherubin, P.; Björner, A.; Knegtering, R.; Parellad 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 59 KB

EPA-1550 - Paliperidone palmitate in acu

✍ Schreiner, A.; Bergmans, P.; Cherubin, P.; Rancans, E.; Bez, Y.; Parellada, E.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 68 KB